Warning! New Side Effect of “Viral” Weight Loss Drugs
Repeat after me: There’s no quick fix for weight loss.
It doesn’t matter if you’re going the route of diet, exercise, juicing, supplements, or prescription drugs.
When it comes to dropping pounds, slow and steady wins the race.
So, when something sounds too good to be true, it probably IS.
This is especially the case for the latest FDA-approved drugs for weight loss.
They promise big results, but what you really could get are BIG health problems.
The drugs semaglutide and liraglutide are called GLP-1 agonists, and they’re marketed under various brand names, including Ozempic and Wegovy.
They were originally designed to treat type 2 diabetes, but their ability to promote weight loss led the FDA to approve two (Wegovy and Zepbound) specifically for this issue.
The fact that they’re approved by the FDA and prescribed by doctors has led to a false sense of security.
In reality, these drugs come with rare but troubling significant side effects. And with millions taking these meds, it could lead to hundreds of thousands of folks battling them.
One of the worst was just confirmed in a recent study.
Researchers examined health insurance claims of more than 16 million people who had been prescribed the two main GLP-1 drugs (semaglutide or liraglutide) between 2006 and 2020.
Compared to folks taking different weight loss drugs, the GLP-1 drugs were associated with…
- 9 times higher risk of pancreatitis
- 22 times higher risk of bowel obstruction
- 67 times higher risk of gastroparesis, or paralysis of the stomach
These aren’t minor side effects. Any of them can dramatically impact overall health AND quality of life.
Just as alarming is that there’s no guarantee that some side effects might not stick around after you stop taking the drug. In fact, CNN covered a story detailing a woman who was experiencing cyclic vomiting syndrome (throwing up multiple times a day) and ongoing nausea and vomiting, which may be linked to the GLP-1 drug she’d been taking.
Now I ask you, is losing weight worth these serious risks?
That’s an easy answer for me. If you’re taking these drugs—or have considered taking them—talk to your doctor about SAFER alternatives.
I don’t blame you for wanting a little extra help when it comes to weight loss, but these drugs are NOT the answer, in my opinion.
P.S. If you subscribe to my newsletter, Natural Health Response, keep your eyes open for the December issue. I’ll reveal even MORE shocking details—plus, I’ll share an alternative that can be just as effective, is significantly cheaper, and doesn’t come with GLP-1 drug risks. Not a subscriber yet? Let’s fix that. CLICK HERE to join us.
SOURCE:
Sodhi M, et al., “Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.” JAMA. Published online October 05, 2023. doi:10.1001/jama.2023.19574
